Armis vs Cylera
A proven horizontal platform against the most elegant idea in the lane. Armis covers everything, IT, OT, IoT, IoMT, cloud, and code across many industries, offers the only on premise option in the category, and holds consecutive Gartner Magic Quadrant Leader placement, but medical device security is one of five products and its detection story stays at platform level. Cylera solves the constraint that defines this category: medical devices cannot be actively scanned while attached to a patient, so its patented Digital Twin emulates each device from network traffic and probes the replica out of band, earning A grades on AI centrality and model transparency that Armis does not hold. What Cylera lacks is evidence, graded C, with no independent benchmark located against Armis's analyst recognition. If your failure mode is breadth across asset classes and industries with deployment flexibility, start with Armis. If your failure mode is rigorous vulnerability testing that never touches live equipment, start with Cylera, and ask it to show twin fidelity against real device behaviour.
- The widest coverage and the only deployment choice: IT, OT, IoT, IoMT, cloud, and code across many industries with on premise, cloud, and hybrid options, graded A on both setting and deployment, where Cylera is healthcare only and cloud based.
- The strongest analyst validation in the lane: named a Leader in the 2026 Gartner Magic Quadrant for CPS Protection Platforms for the second consecutive year, against Cylera, which no independent benchmark or KLAS score was located for.
- Proven scale: correlates device context, behavioural anomalies, vulnerability intelligence, and business impact into a unified risk model across a large multi industry install base.
- The most rigorous non invasive testing in the category: the patented Digital Twin emulates each device from network traffic and probes the replica out of band, so vulnerability testing never touches equipment attached to a patient, graded A on model transparency where Armis grades C.
- The AI does the primary work: constructing a behavioural replica accurate enough that probing it yields valid findings about the real device is a substantive modelling problem, and the platform classifies zero day devices it has never seen, graded A on AI centrality against Armis at B.
- Purpose built for hospitals rather than adapted from a general IoT product, with device utilisation analytics that also serve biomedical engineering and capital planning.
Side-by-Side
| Axis | A Armis |
C Cylera |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
The grades split by what each vendor is: Armis is a horizontal platform graded B on AI centrality because medical device security is one of five products, and C on model transparency for platform level language without a named detection methodology; Cylera grades A on both because the Digital Twin is a specific, patented, publicly readable mechanism and the ML is the whole product. The reverse caution is Cylera's evidence: graded C, with no KLAS score or independent benchmark located and Gartner reviewers describing its vulnerability assessment as still maturing, where Armis holds consecutive Gartner Magic Quadrant Leader placement. The single technical question to press Cylera on is twin fidelity, since findings only transfer if the replica faithfully matches the device. Neither publishes a security attestation, shared across the category. Armis has announced a planned ServiceNow acquisition expected in the second half of 2026. Neither publishes pricing.